首页   按字顺浏览 期刊浏览 卷期浏览 Clinical Use of Human Hepatocyte Growth Factor in the Early Detection of HELLP Syndrome
Clinical Use of Human Hepatocyte Growth Factor in the Early Detection of HELLP Syndrome

 

作者: Hideaki Iioka,  

 

期刊: Gynecologic and Obstetric Investigation  (Karger Available online 1996)
卷期: Volume 41, issue 2  

页码: 103-105

 

ISSN:0378-7346

 

年代: 1996

 

DOI:10.1159/000292052

 

出版商: S. Karger AG

 

关键词: Human hepatocyte growth factor;HELLP syndrome

 

数据来源: Karger

 

摘要:

The change in plasma concentration of human hepatocyte growth factor (hHGF) in pregnant women with HELLP (hemolysis, elevated liver enzyme and low platelets) syndrome was investigated, and the following results were obtained. (1) The plasma concentration of hHGF in pregnant women did not change with the gestational stage. (2) The plasma concentration of hHGF in pregnant women with EPH (edema, proteinuria and hypertension) gestosis was 0.19 ± 0.07 ng/ml and did not differ greatly from that in control pregnant women. (3) The plasma concentration of hHGF in pregnant women with HELLP syndrome was 1.79 ± 0.35 ng/ml; it was increased prominently compared to control pregnant women. (4) The plasma concentration of hHGF in pregnant women with HELLP syndrome changed parallel to the clinical symptoms of the syndrom

 

点击下载:  PDF (1249KB)



返 回